ChromaDex Corp.

CDXC on NASDAQToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
3.34US -0.02/-0.60%145,0002.79 / 5.99184.04 M

Contact Information

ChromaDex Corp.

Headquarters:
10005 Muirlands Blvd., Suite G
Irvine, California
USA, 92618
Tel: 949-419-02988
Fax: 949-419-0294
Email: Send a message
Website: Visit website
For more information...
Retail: Shushu Feng
Institutional: Sally Wallick

ChromaDex Corp. is an integrated, global nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts.

Frank L. Jaksch, Jr. - Co-founder, Executive Chairman of the Board

Rob Fried -Chief Executive Officer

Kevin Farr - Chief Financial Officer

Mark Friedman - General Counsel and Corporate Secretary

Lisa Bratkovich - Chief Marketing Officer

Ben Shichman - Chief Technical Officer

Troy Rhonemus - Executive Vice President

Amy Boileau, Ph.D., RD. - Vice President, Research & Development

Jordan Gropack - Vice President of People

Frank L. Jaksch Jr. - Co-founder, Executive Chairman of the Board

Rob Fried - Chief Executive Officer

Jeff Baxter - Non-Executive Director

Steven A. Block - Non-Executive Director

Kurt Gustafson - Non-Executive Director

Tony Lau - Non-Executive Director

Steven D. Rubin - Non-Executive Director

Wendy Yu - Non-Executive Director

Stock Information

Company Overview

ChromaDex Corp. is an integrated, global nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to uncover the full potential of NAD and identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts.

Management

Frank L. Jaksch, Jr. - Co-founder, Executive Chairman of the Board

Rob Fried -Chief Executive Officer

Kevin Farr - Chief Financial Officer

Mark Friedman - General Counsel and Corporate Secretary

Lisa Bratkovich - Chief Marketing Officer

Ben Shichman - Chief Technical Officer

Troy Rhonemus - Executive Vice President

Amy Boileau, Ph.D., RD. - Vice President, Research & Development

Jordan Gropack - Vice President of People

Board of Directors

Frank L. Jaksch Jr. - Co-founder, Executive Chairman of the Board

Rob Fried - Chief Executive Officer

Jeff Baxter - Non-Executive Director

Steven A. Block - Non-Executive Director

Kurt Gustafson - Non-Executive Director

Tony Lau - Non-Executive Director

Steven D. Rubin - Non-Executive Director

Wendy Yu - Non-Executive Director

Contact Information

Headquarters:
10005 Muirlands Blvd., Suite G
Irvine, California
92618, USA
Telephone: 949-419-02988
Fax: 949-419-0294
Email: Send a message
Website: Visit website